Yahoo! Finance: Biotechnology Industry News: Epizyme, Inc. Publishes Data Demonstrating EPZ-5676 as Potent, Selective Inhibitor of DOT1L for Genetically Defined Acute Leukemias

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Epizyme, Inc. Publishes Data Demonstrating EPZ-5676 as Potent, Selective Inhibitor of DOT1L for Genetically Defined Acute Leukemias Jun 26th 2013, 12:30 [PR Newswire] - CAMBRIDGE, Mass., June 26, 2013 /PRNewswire/ -- Epizyme, Inc ., (NASDAQ: EPZM) a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions